Bayer Can't Sink Whistleblower's Drug Kickback Claims
A New Jersey federal judge on Friday narrowed a Bayer Corp. whistleblower's suit over alleged False Claims Act infractions tied to two drugs, tossing claims for violative off-label marketing but not...To view the full article, register now.
Already a subscriber? Click here to view full article